Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600E Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

Hiroshi Yokomichi; Takashi Inozume; Makoto Wada; Jun Asai; Hiroshi Igaki; Kenjiro Namikawa; Ayato Hayashi; Satoshi Fukushima; Taku Fujimura; Hiroshi Koga; Yasuhiro Nakamura; Mie Mochizuki; Zentaro Yamagata

doi:10.31662/jmaj.2020-0016

Short Communication

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) ^V600E Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

Hiroshi Yokomichi, Takashi Inozume, Makoto Wada, Jun Asai, Hiroshi Igaki, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Hiroshi Koga, Yasuhiro Nakamura, Mie Mochizuki, Zentaro Yamagata

Author information

Hiroshi Yokomichi
Department of Health Sciences, University of Yamanashi, Chuo, Japan
Takashi Inozume
Department of Dermatology, University of Yamanashi, Chuo, Japan
Makoto Wada
Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Jun Asai
Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Hiroshi Igaki
Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan
Kenjiro Namikawa
Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan
Ayato Hayashi
Department of Plastic and Reconstructive Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan
Satoshi Fukushima
Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
Taku Fujimura
Department of Dermatology, Tohoku University, Sendai, Japan
Hiroshi Koga
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Yasuhiro Nakamura
Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Hidaka, Japan
Mie Mochizuki
Department of Pediatrics, University of Yamanashi, Chuo, Japan
Zentaro Yamagata
Department of Health Sciences, University of Yamanashi, Chuo, Japan

Keywords: melanoma, BRAF^V600E, primary tumor, metastasis, BRAF mutation, disagreement, serine-threonine protein kinase BRAF inhibitor, mitogen-activated protein kinase kinase inhibitor

JOURNAL OPEN ACCESS
Supplementary material

2020 Volume 3 Issue 3 Pages 274-279

DOI https://doi.org/10.31662/jmaj.2020-0016

Details

Corresponding author

Register with J-STAGE for free!